Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
204.86
-0.25 (-0.12%)
Sep 15, 2026, 4:00 PM EDT - Market closed

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
43,90915,3988,0834,7202,1151,855
Market Cap Growth
404.60%90.50%71.26%123.15%14.03%-29.43%
Enterprise Value
41,16113,8816,6203,9691,5251,278
Last Close Price
204.8679.6543.7428.6823.8225.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---407.5859.7863.11
PB Ratio
16.849.443.572.583.093.08
P/TBV Ratio
17.329.873.682.693.463.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---342.7843.1143.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.260.060.050.090.11
Net Debt / Equity Ratio
-1.05-0.98-0.95-0.97-0.85-0.85
Net Debt / EBITDA Ratio
1.701.363.153.752.282.76
Net Debt / FCF Ratio
2.231.753.794.932.473.32
Asset Turnover
---0.010.050.05
Quick Ratio
11.126.9813.9712.8910.489.66
Current Ratio
11.387.1514.2013.0610.659.77
Return on Equity (ROE)
-79.09%-58.07%-29.33%-34.75%-38.63%-34.73%
Return on Assets (ROA)
-30.12%-30.08%-18.66%-20.71%-20.83%-18.00%
Return on Capital Employed (ROCE)
-41.00%-57.30%-28.80%-24.80%-34.40%-27.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.03%-7.35%-7.42%-9.25%-11.76%-10.09%
FCF Yield
-2.81%-5.93%-7.02%-7.59%-11.12%-8.29%
Buyback Yield / Dilution
-10.45%-13.35%-48.24%-40.34%-10.74%-32.68%
SEC Filings: 10-K · 10-Q